---
title: 'Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring,
  molecular brain imaging and pharmacogenetic tests: focus on antipsychotics'
date: '2024-06-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38913780/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240625182106&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: All three tools discussed in these Guidelines are essential
  for drug treatment. TDM goes well beyond typical indications such as unclear compliance
  and polypharmacy. Despite its enormous potential to optimize treatment effects,
  minimize side effects and ultimately reduce the global burden of diseases, personalized
  drug treatment has not yet become the standard of care in ...'
disable_comments: true
---
CONCLUSION: All three tools discussed in these Guidelines are essential for drug treatment. TDM goes well beyond typical indications such as unclear compliance and polypharmacy. Despite its enormous potential to optimize treatment effects, minimize side effects and ultimately reduce the global burden of diseases, personalized drug treatment has not yet become the standard of care in ...